Press Releases for VIVO

Press Releases
Meridian Bioscience Reports Record Fiscal 2009 Operating Results, Increases Regular Cash Dividend Rate, and Reaffirms Guidance
Meridian Bioscience Europe Announces Agreement to Distribute Test For GI Disease
Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal 2010 and Reaffirms Fiscal 2009 Guidance
Meridian Bioscience to Present at the Robert W. Baird 2009 Health Care Conference
Meridian Bioscience Appoints James M. Anderson to Board of Directors
Meridian Bioscience Reports Record Sales and Operating Results, Declares Regular Cash Dividend, Reaffirms Fiscal 2009 Guidance, and Comments on Timing of Fiscal 2010 Guidance
FORTUNE Small Business Again Lists Meridian Bioscience as One of America’s Fastest-Growing Small Companies
Meridian Bioscience to Present at the William Blair and Company’s 29th Annual Growth Stock Conference
Meridian Bioscience Wins GHX 2009 Best in Class Award
Meridian Bioscience Receives FDA Clearance for New Rapid Campylobacter Test
Meridian Bioscience Reports Record Second Quarter and Six Months Operating Results, Declares Regular Cash Dividend, and Revises Downward Fiscal 2009 Guidance
Meridian Bioscience Receives FDA Clearance for New Campylobacter Test
Meridian Bioscience Announces Two New Exclusive International Distribution Agreements in Australia and Argentina
Meridian Bioscience Reports Record First Quarter Sales and Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2009 Guidance
Meridian Bioscience, Inc. Announces Preliminary First Quarter Operating Results and Revises Fiscal 2009 Revenue Guidance
Meridian Bioscience to Participate in Panel Presentation at RBC Capital Markets 2008 Healthcare Conference
Meridian Bioscience Announces Filing of Shelf Registration Statement to Replace Expiring Registration Statement
Meridian Bioscience to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
Meridian Bioscience Reports Record Fiscal 2008 Operating Results, Increases Regular Cash Dividend Rate, and Reaffirms Guidance
New Molecular Test for C. difficile from Meridian Bioscience Expected to be Launched in Fiscal Year 2009
Meridian Bioscience to Present at the William Blair and Company Small-Cap Growth Stock Conference
Meridian Bioscience to Present at the 2008 UBS Global Life Science Conference
Meridian Bioscience Announces New Exclusive Canadian Distribution Agreement with Somagen Diagnostics
Meridian Bioscience to Present at the Robert W. Baird 2008 Small Cap Healthcare Conference
Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal 2009 and Reaffirms Fiscal 2008 Guidance
Meridian Bioscience Reports Record Operating Results, Declares Regular Cash Dividend, Reaffirms Fiscal 2008 Guidance, and Comments on Fiscal 2009 Outlook
Fortune Small Business Lists Meridian Bioscience as One of America's Fastest-Growing Small Companies
Meridian Bioscience Completes Acquisition of Recombinant Protein Technologies and Products from Vybion, Inc.
Meridian Signs Agreement in Principle to Acquire Line of Recombinant Proteins from Vybion, Inc. - May 27 2008 12:42AM
Meridian Bioscience to Present At the Nasdaq 21st Investor Program, London
Meridian Bioscience to Present at the Robert W. Baird 2008 Growth Stock Conference - Jun 2 2008 2:04AM
Meridian Bioscience Reports Record Second Quarter and Six Months Operating Results
Meridian Bioscience Launches Two New TRU(TM) Brand Rapid Tests for the Detection of Epstein-Barr Virus